Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non-Current Assets: 2019-2023

Historic Other Non-Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $1.0 million.

  • ADC Therapeutics' Other Non-Current Assets rose 13.79% to $1.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0 million, marking a year-over-year increase of 13.79%. This contributed to the annual value of $902,000 for FY2022, which is 30.16% up from last year.
  • Per ADC Therapeutics' latest filing, its Other Non-Current Assets stood at $1.0 million for Q3 2023, which was down 29.11% from $1.4 million recorded in Q2 2023.
  • ADC Therapeutics' Other Non-Current Assets' 5-year high stood at $1.4 million during Q2 2023, with a 5-year trough of $384 in Q2 2020.
  • Moreover, its 3-year median value for Other Non-Current Assets was $899,000 (2022), whereas its average is $871,909.
  • Data for ADC Therapeutics' Other Non-Current Assets shows a peak YoY skyrocketed of 177,534.96% (in 2021) over the last 5 years.
  • Over the past 5 years, ADC Therapeutics' Other Non-Current Assets (Quarterly) stood at $368,000 in 2019, then reached $389 in 2020, then spiked by 177,534.96% to $693,000 in 2021, then spiked by 30.16% to $902,000 in 2022, then increased by 13.79% to $1.0 million in 2023.
  • Its Other Non-Current Assets was $1.0 million in Q3 2023, compared to $1.4 million in Q2 2023 and $1.2 million in Q1 2023.